Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMA & BIOTECH
INDUSTRY : MAJOR PHARMACEUTICALS
REPLIGEN CORP.
Repligen Corp.
XNAS: RGEN
Momentum Trap
Download real time
124.78
3.10
(
2.55
%)
31.63% Fall from 52W High
277.4K
XNAS Volume
XNAS
26 Sep, 2025 2:40 PM (EDT)
Watchlist
Portfolio
Alert
My Notes
Overview
Buy Sell Zone
Financials
Technicals
Share Price History
Ownership
Politician Trades
Insider Deals
Corporate Actions
All
Dividend
Split
Board Meetings
About
Repligen Corp. - RGEN - stock price prediction, stock price target, analyst ratings from 21 analysts
Repligen Corp. has a share price target of US$ 181, revenue growth forecast of 14.5%, and profit growth estimate of 299.7% for FY25, based on top 21 analyst calls.
Forecaster Screeners